Accretion Pharmaceuticals IPO GMP Live, Open Date, Close Date, Price Band

Accretion Pharmaceuticals IPO open date is May 14, 2025, and the closing date is May 16, 2025. This new IPO is a book-built price issue worth up to Rs 29.75 crores. This upcoming IPO is offering entirely fresh issues of up to 29,46,000 equity shares worth up to Rs 29.75 crore. 

Accretion Pharmaceuticals IPO issue price band is Rs 96 to Rs 101 per share. As of now, the live GMP of the Accretion Pharmaceuticals IPO is at 0, indicating neutral sentiment and low interest among investors for this IPO.

Accretion Pharmaceuticals IPO lot size is 1,200 shares, and the allotment status will be finalised on Monday, May 19, 2025. The minimum investment for retail investors is Rs 1,21,200. The registrar for the Accretion Pharmaceuticals IPO is Kfin Technologies Limited. The listing date is Wednesday, May 21, 2025.

Also Read | Top 5 Biggest Upcoming IPOs of 2025: Zepto IPO, Flipkart IPO and More

Accretion Pharmaceuticals IPO GMP Live

Accretion Pharmaceuticals IPO GMP is at Rs 0. The IPO GMP today indicates the huge interest of retail investors. It is expected that the listing price can be near at Rs 101 per share. You can check the latest IPO Grey Market Premium today online.

Accretion Pharmaceuticals IPO Price Band

Accretion Pharmaceuticals IPO price band is Rs 96 to Rs 101 per share. The minimum amount required for retail investors to participate in this IPO is Rs 1,21,200 (101 x 1,200 shares). However, for the HNI category, the minimum investment amount required is Rs 2,42,400 (101 x 2400 shares).

Accretion Pharmaceuticals Allotment Status

Accretion Pharmaceuticals IPO Allotment status is available on its registrar Kfin Technologies Limited website on Monday, May 19, 2025. Once the subscription ends after the closing of IPO bidding, the allotment status of investors who applied for IPO will be available on the registrar's website.

Accretion Pharmaceuticals Listing Date

Accretion Pharmaceuticals IPO listing date is Wednesday, May 21, 2025. The Listing will be on the NSE SME platform. Retail investors can sell the shares after 10 AM on the listing day.

Accretion Pharmaceuticals IPO: Listing Date, Lot Size, Issue Size, Price Band

Accretion Pharmaceuticals Limited: About the Company

Accretion Pharmaceuticals Limited, established in 2012 in Ahmedabad, Gujarat, began as a partnership with a vision to deliver healthcare products of international quality at competitive prices. In 2023, the company transitioned into a limited entity, marking a significant milestone in its growth journey. 

Today, Accretion is a conglomerate comprising four robust companies and a dedicated team of over 400 professionals. The company’s WHO-cGMP and GLP-certified manufacturing facilities enable the production of a diverse portfolio, including tablets, capsules, oral liquids, topical preparations, and oral powders. 

Accretion operates in more than 30 countries, continually expanding its global footprint while upholding its core philosophy of “Growing Together”-fostering collaborative relationships with employees, customers, and partners. Driven by a commitment to quality, innovation, and accessibility, Accretion Pharmaceuticals Limited aims to empower healthier lives and shape the future of healthcare with a focus on Ayurveda, nutraceuticals, and pharmaceutical solutions.

Accretion Pharmaceuticals IPO Objectives

Accretion Pharmaceuticals IPO objectives include utilising the funding received from the fresh issue or capital expenditure on the purchase of new equipment and machinery, as well as for upgrading its existing manufacturing facility. Additionally, funds will be allocated for repayment/prepayment of certain borrowings, meeting working capital requirements, and addressing general corporate purposes.

Accretion Pharmaceuticals IPO: Key Dates, Allotment, Listing Date

Accretion Pharmaceuticals IPO Promoter Holdings

Accretion Pharmaceuticals IPO promoters are Mr. Mayur Popatlal Sojitra, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel and Mr. Hardik Mukundbhai Prajapati. Their combined shareholding before the IPO was 100%; post-IPO, their shareholdings will be going to decline to 73.48%.

Accretion Pharmaceuticals Limited Financials (Amt in Rs Cr)

Lead Manager and Registrar of Accretion Pharmaceuticals IPO

Accretion Pharmaceuticals lead manager is Jawa Capital Services Private Limited. The company has appointed Kfin Technologies Limited as the registrar for this public issue.

How to apply for the Accretion Pharmaceuticals IPO

Interested investors who want to apply for the Accretion Pharmaceuticals IPO can directly apply from the Bigul trading app, or you can apply on the Bigul website by visiting here. You can also check the details of the upcoming IPO on the Bigul platform.

Accretion Pharmaceuticals IPO FAQs

1. What are the core details available of the Accretion Pharmaceuticals IPO?

Accretion Pharmaceuticals IPO is a book-built price issue worth up to Rs 29.75 crores. The price band for this IPO is Rs 96 – Rs 101 per share. This upcoming IPO is offering entirely a fresh issue of 29,46,000 equity shares worth up to Rs 29.75 crore.

2. What is the Accretion Pharmaceuticals IPO open date and close date?

Accretion Pharmaceuticals IPO subscription opens on May 14, 2025, and closes on May 16, 2025.

3. What is Accretion Pharmaceuticals IPO GMP Live?

Accretion Pharmaceuticals IPO GMP is at Rs 0. The IPO GMP today indicates the huge interest of retail investors. It is expected that the listing price can be the same or near the allotment price, which is Rs 101 per share. You can check the latest IPO Grey Market Premium today online.

4. How do you check the IPO Allotment status?

Accretion Pharmaceuticals IPO Allotment status is available on its registrar, Kfin Technologies Limited website. Once the IPO subscription ends after the closing of IPO bidding, the allotment status of investors who applied for IPO will be available on the registrar's website.

5. Who are the registrar and lead managers of Accretion Pharmaceuticals IPO?

Accretion Pharmaceuticals IPO lead manager is Jawa Capital Services Private Limited. The company has appointed Kfin Technologies Limited as the registrar for this public issue.

Also Read:

• What is IPO?
• What is IPO GMP?
• Difference between IPO and FPO For Beginners
• Difference between SME IPO and Mainline IPO?